Browse Research Interests
 | | |
|---|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
| Associate Professor Mike Bennett
Prince of Wales Clinical School - Department of SurgeryStatement of Interests:
The field of Hyperbaric Medicine is regarded with great suspicion by many medical graduates. This is due at least in part to both widespread ignorance of the effects of high doses of oxygen, and a poor clinical research base. In this regard, the appropriate collation, critical appraisal and meta-analysis of comparative clinical trials is of great interest. Work is underway with colleagues from the USA, UK and Germany to produce a systematic appraisal of the evidence-basis for the use of hyperbaric oxygenation.
More...
| |
| Professor Nicholas Buckley
Prince of Wales Clinical SchoolStatement of Interests:
As part of the SACTRC collaboration I have helped developed a centre of clinical toxicology research excellence in Sri Lanka – largely funded by the NHMRC and Wellcome Trust International Collaborative Research Grant scheme. The main focus of this work is pesticide poisoning, although the collaboration began with trials on snake envenomation and oleander poisoning and continues to be active in researching these areas and in other community based public and mental health projects.
More...
| |
| Dr Limin Mao
Prince of Wales Clinical SchoolStatement of Interests:
Cancer epidemiology, HIV/AIDS and its risky behaviors, and primary health care are of particular interest.
More...
| |
| Dr Sallie-Anne Pearson
Prince of Wales Clinical SchoolStatement of Interests:
Sallie is a health service researcher specialising in clinician behaviour change, pharmacoepidemiology and pharmaceutical policy evaluation. She has conducted this research in Australia, the United States and the developing world. Sallie completed her doctoral training in 1998 at the University of Newcastle, Australia and was the inaugural Postdoctoral Fellow in Pharmaceutical Policy at Harvard Medical School from 2000-2001. She returned to Australia in 2002 where she worked as a consultant to the WHO Collaborating Centre in Pharmaceutical Policy Boston and Medicare Australia for two years. She returned to academia in 2004 and in March 2006 joined the Integrated Cancer Research Group as the Pharmacoepidemiology and Pharmaceutical Policy Team Leader. She is currently a Cancer Institute NSW Health Services Research Fellow (2006-2009). Sallie's current research interests focus on three core areas: 1. Using secondary data sources to investigate the use and impact of medicines in real world clinical prcatice 2. Clinician behaviour change, specifically the use and uptake of electronic decision support to guide prescribing practice 3. Investigating the direct and indirect costs of cancer care from the perspective of health care payers and patients
More...
| |
| Dr Claire Vajdic
Prince of Wales Clinical SchoolStatement of Interests:
The epidemiology of cancer in relation to immunodeficient states, such as HIV/AIDS infection, solid organ transplantation, haematopoietic stem cell transplantation, and primary immune deficiency. The epidemiology and prevention of cancer, in particular lymphoma. Epidemiological methods, with an emphasis on exposure assessment. Ongoing interest in malignancies associated with sun exposure, in particular, melanoma of the eye.
More...
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |